Skip to content
Investing

Reconnaissance Energy Africa: An Explorer Waiting on Its First Measured Flow in Namibia

ReconAfrica explores the Kavango Basin in Namibia and holds an offshore block in Gabon. It has no revenue and funds itself with share sales. Its assets, cash, risks and the dates that matter next.

A ReconAfrica drilling rig and its site camp in north-east Namibia, silhouetted against an orange sunrise.
Photo: Reconnaissance Energy Africa

Reconnaissance Energy Africa, known as ReconAfrica, is a Canadian explorer testing a new oil and gas basin in north-east Namibia. It has found hydrocarbons at its Kavango West 1X well but has not yet measured a flow rate. A horizontal test now under way is meant to change that before the end of 2026. Here is what the company holds, how it pays for its work and what could go wrong.

What ReconAfrica does

ReconAfrica is an exploration company. It has no production and no revenue, and it pays for drilling and testing by selling shares. Its shares trade on the TSX Venture Exchange, the OTCQX in New York, the Frankfurt exchange and the Namibian Stock Exchange.

The company says it has licences and access over about 13 million contiguous acres in Namibia, Botswana and Angola, in the Damara Fold Belt and the Kavango Rift Basin under the Kalahari Desert. It also holds an offshore block in Gabon.

Reconnaissance Energy Africa: share price, chart and news

A rig worker in a hard hat operates the levers of a drilling control panel at a ReconAfrica well site.
A rig worker in a hard hat operates the levers of a drilling control panel at a ReconAfrica well site. Photo: Reconnaissance Energy Africa

The assets

AssetWhereReconAfrica's interestStatus
PEL 73North-east Namibia; 25,341 sq km Namibian licence area70%, operatorKavango West 1X discovery; horizontal flow test under way
PEL 001North-west Botswana, 7,592 sq km100%, per the company websiteLicence ran to June 2024 with a right to extend; extension request under government review
Angola MOU areaAngolaMemorandum of understanding acreageSoil sampling done in May and June; 2D seismic possibly in 2027
Ngulu blockOffshore central Gabon, 1,214 sq km55%, operatorSeismic reprocessing over the Loba oil discovery

In Gabon, ReconAfrica signed a production sharing contract for the offshore Ngulu block and is operator with 55%. The block covers 1,214 sq km, which the company compares to 54 Gulf of Mexico blocks, and contains the Loba oil discovery as well as pre-salt and post-salt prospects. Existing 3D seismic is being reprocessed with full waveform inversion, a technique meant to sharpen the image of the oil-bearing reservoirs at Loba and of salt-related targets.

In Angola, soil samples taken in May and June suggest a working petroleum system similar to the Namibian side of the play, according to the company's preliminary reading.

On PEL 73, BW Energy holds 20% under an agreement signed in 2024 that closed in 2025, and Namibia's state oil company NAMCOR holds 10%, carried to development. The licence's current exploration period was extended by one year to 29 January 2027.

Kavango West 1X so far

Log analysis at KW1X identified six zones for testing, three in the Elandshoek and three in the Huttenberg. The company's April plan put them at 45 to 75 metres thick within about 420 metres of hydrocarbon-saturated section. The Huttenberg alone holds about 75 metres of pay on the original log analysis.

Vertical testing began in 2026. In July the company reported hydrocarbons flowing from the upper Elandshoek, and in August natural gas with possible liquids from the upper Huttenberg. No rate was measured either time because of equipment limits. Laboratory work on samples points to thermogenic gas with liquid potential, at a maturity described as late oil to early gas.

The company concluded that a cased vertical well was the wrong design for a fractured reservoir. On 19 October it began a horizontal sidetrack of up to 1,000 metres into the upper Huttenberg, completed open hole to cross as many natural fractures as possible. A flow test of up to a month follows, and results are expected before year-end.

In September chief executive Brian Reinsborough said a flow rate and liquids content were "essential for moving towards a Final Investment Decision".

Money and shares

Funding in 2026

  • C$36.8m underwritten offering closed in January
  • C$21.9m bought deal closed on 10 September
  • C$24.2m cash at 30 June 2026

ReconAfrica has raised money twice this year. The September deal sold 29.9 million units at C$0.73, each one share and half a warrant exercisable at C$0.93 until September 2029. Warrant exercises brought in a further C$5.0 million in the first half and C$0.6 million after it.

The company reported a cash balance of C$24.2 million at 30 June, before the September raise. Its releases did not give a current share count. In August it said its fully diluted share count had fallen by about 10% so far this year, and listed warrants priced at C$1.75 expired on 31 July.

The board added Ryan Kubik as an independent director on 1 October. In January the company adopted a shareholder rights plan, a measure that makes an unsolicited takeover harder to complete without the board's agreement.

Risks and what to watch

  • Geological risk. Hydrocarbons have flowed, but no commercial rate has been shown. A weak horizontal test would undercut the case for development.
  • Funding and dilution. With no revenue, every phase of work depends on new money. Each share sale so far has added warrants as well as shares.
  • Licence timing. The current PEL 73 exploration period ends on 29 January 2027, only weeks after the test results are due.
  • Remote operations. Equipment, permits and service providers have already caused delays at KW1X.
  • Development hurdles. Even after a good test, a final investment decision needs appraisal wells, reserves, partner approval, offtake for gas and large capital.

Dates and milestones

  • Before the end of 2026: KW1X horizontal flow test results, the first measured rates
  • Before the end of 2026: completion of the Ngulu seismic reprocessing in Gabon, then a resource report and appraisal well planning for Loba
  • After KW1X: a horizontal test at the Kavango West 2A appraisal well
  • 29 January 2027: end of the current PEL 73 exploration period
  • 2027: possible 2D seismic in the Angola MOU area

ReconAfrica has spent years establishing that the Kavango basin holds hydrocarbons. The coming weeks test something different: whether a well there can flow at rates worth developing.

Sources

Related stories

Business

Reconnaissance Energy Africa Starts Horizontal Drilling at KW1X, Flow Test Due by Year-End

ReconAfrica has started a sidetrack of up to 1,000 metres at its Kavango West 1X discovery in Namibia, funded by a C$21.9m share sale, and expects to publish flow test results…

Investing

Bannerman Energy Profile: Building Namibia's Etango Uranium Mine With a CNNC Partner

Bannerman Energy is building the Etango uranium mine in Namibia with CNNC's overseas arm. Its cash, share count, mine plan, sales terms and the dates to watch before first output…

Investing

DMG Blockchain Solutions: A Bitcoin Miner Trying to Turn Its BC Site Into an AI Data Centre

DMG Blockchain Solutions mines bitcoin in British Columbia, runs custody and software businesses and wants to host AI servers. Its numbers, balance sheet, risks and the milestones…

Investing

Kraken Robotics: An Investor Profile of the Subsea Sonar and Battery Maker After Covelya

Kraken Robotics sells sonar, subsea batteries and survey services to navies and offshore energy. What the C$615m Covelya deal changed, the latest numbers, the risks and what to…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…